A Study of Sleeve Gastrectomy Risks and Benefits

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

March 31, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Renal Failure
Interventions
DIAGNOSTIC_TEST

6 minutes walk distance

Subjects walk as far as possible for 6 minutes at a self-selected pace, and the total distance walked will be recorded

BEHAVIORAL

Activity Monitor

Subjects will wear an Actigraph on their wrist like a watch for up to 10 days at home to monitor activity.

BEHAVIORAL

Continuous Glucose Monitor

Subjects will collect glucose values in the fluid under their skin for up to 10 days at home.

BEHAVIORAL

Blood Pressure Monitoring

Subjects will monitor their blood pressure at home for 10 consecutive days 3 times a day

DIAGNOSTIC_TEST

Blood Pressure Monitoring

24-hour ambulatory blood pressure monitoring

DIAGNOSTIC_TEST

Body Composition Scan

Measure of body fat percentage, skeletal muscle mass, body water, and visceral fat.

DIAGNOSTIC_TEST

Mixed meal testing

Subjects will consume 6 ml/kg body weight of Boost, up to maximum of 360 ml, within 5 min

DIAGNOSTIC_TEST

Quality of Life

Subject will complete Quality of Life Questionnaire

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT06075511 - A Study of Sleeve Gastrectomy Risks and Benefits | Biotech Hunter | Biotech Hunter